B O O K - American College of Rheumatology

• describe the role of IL-1 and IL-6 in the development of
juvenile idiopathic arthritis and its therapeutic implications
• develop a plan for management of ‘resistant cases’ of juvenile
idiopathic arthritis
ACR Practice Issues
9:30 - 11:00 am
A411
CORC Forum: Health Care Reform – Where Are We
Heading? BR cP PS
Moderators: Matthew P. Bunyard, MD; Cleveland Clinic
Foundation; Cleveland, OH
Raymond Hong, MD, MBA; Ohio Permanente Medical Group;
Richfield, OH
9:30 am
Where Are We Heading? Health Care Reform – A Workable
Approach
J. B. Silvers, PhD; Case Western Reserve University; Cleveland,
OH
Nan Shen, MD; Shanghai Ren Ji Hospital; Shanghai, China
Speaker: Angus W. Thomson, PhD; Univesity of Pittsburgh
Medical School; Pittsburgh, PA
Session Overview:
Dendritic cells are pivotal regulators of the immune response.
Dendritic cells sense pathogens and danger signals in the
environment and trigger antigen specific immune responses.
They also present antigens from self-tissues to induce immune
tolerance. Recent studies have unveiled the mechanisms
by which dendritic cells promote and maintain tolerance. In
addition, tolerogenic dendritic cells can promote or restore
antigen-specific tolerance in animal models and these cells hold
promise for the treatment of human autoimmune diseases.
Upon completion of this session, participants should be able to:
• discuss how dendritic cells establish and maintain immune
tolerance
• explain how manipulation of dendritic cells can generate
tolerogenic dendritic cells
• describe how tolerogenic dendritic cells can be effective for
the treatment of human autoimmune disease
10:15 am
The Need for Strategic Planning in a Time of Change
John Freedman, MD, MBA; Freedman Healthcare, LLC; Newton,
MA
Session Overview:
Health care reform is at the forefront of health care discussion
today. The business case for quality and efficiency in health care
has never been clearer. It has been postulated that the new
system will encourage payers to reimburse only for consistent
and efficient care. Increasing transparency will stimulate more
patient ownership of their health concerns and finances.
Patients will in turn demand care that meets their needs.
Preparing for the future of health care is therefore critical to
the survival of many organizations. This changing health care
landscape will have implications for medical providers. Many
agree that the current system is not working and something
will need to be done in order to protect the physician-patient
relationship. So where are we heading?
Upon completion of this session, participants should be able to:
• discuss the role of performance measurement in payment
health care reform
• identify opportunities for providers in the changing medical
landscape
• describe the risks for clinicians, medical equipment and
pharmaceutical suppliers, and others as a result of health care
reform
ACR State-of-the-Art Lecture
9:30 - 10:30 am
B313
Tolerogenic Dendritic Cells: Regulators of Immune
Reactivity and Therapeutic Agents in Autoimmune
Disease R
Moderators: Christopher T. Ritchlin, MD; University of Rochester
Medical Center; Rochester, NY
InnoVAtion Theater
10:00 - 10:45 am
Halls A1 & A2 (Booth #555)
The following non-CME activity has been planned and will be
implemented in accordance with the requirements of the FDA
and applicable standards of the PhRMA Code on Interactions
with Healthcare Professionals by Covidien. Please visit the
Covidien exhibit booth for more information or see page 292.
Seating and light refreshments are subject to availability.
An Alternative for Patients with Signs and Symptoms
of Osteoarthritis of the Knee(s)
ACR Workshops
10:30 am - 12:30 PM
Admission to each Workshop requires a separate registration
and ticket. To verify which session you registered for, check to
make sure the registration code on your ticket matches the code
listed below in parentheses.
B201
Electronic Health Record (235) PS
Speaker: Salahuddin Kazi, MD; Dallas Veterans Affairs Medical
Center; Dallas, TX
Upon completion of this session, participants should be able to:
• identify the key elements in current clinical processes and
workflow to help select the features of an electronic health
record that will be most useful for the clinical practice
• define “meaningful use” of EHR
• establish the principles of medical informatics and how to
apply them to a clinical setting
B202
Muscle Involvement in Rheumatic Diseases (236)
Speaker: Sakir Humayun Gultekin, MD; Oregon Health & Science
University; Portland, OR
2010 Program Book 101
wednesday